GW is a pharmaceutical group developing a portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic conditions. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group s lead programme is the development of a product portfolio of cannabinoid prescription medicines , including Sativex Oromucosal Spray, to meet patient needs in a wide range of therapeutic indications lt br / gt GW has assembled a large in house team with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant based prescription pharmaceutical products. GW also holds GMP manufacturing licences for the manufacture of pharmaceutical products for both clinical trials and commercial purposes.
Quote | GW Pharmaceuticals (OTCMKTS:GWPRF)
Last: | $17 |
---|---|
Change Percent: | 0.0% |
Open: | $17 |
Close: | $17 |
High: | $17 |
Low: | $17 |
Volume: | 767 |
Last Trade Date Time: | 06/21/2021 04:41:33 am |
News | GW Pharmaceuticals (OTCMKTS:GWPRF)
Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financial conditions. Owning the "Pharmland" - the physical real estate - had been one of the...
Merger activity remained steady last week with six new deals announced. Kansas City Southern receives new superior offer. Three new bank mergers announced last week. For further details see: Merger Arbitrage Mondays - Bank Mergers Dominate
Message Board Posts | GW Pharmaceuticals (OTCMKTS:GWPRF)
Subject | By | Source | When |
---|---|---|---|
Does GWPRF have a new stock symbol now? | 8mileshigh | investorshub | 07/08/2021 9:57:16 AM |
GWPRF: Jazz Pharmaceuticals acquired GW Pharmaceuticals PLC for | Renee | investorshub | 06/21/2021 11:19:54 PM |
Back to green. | JohnCM | investorshub | 01/22/2020 1:52:42 PM |
whytestocks: $GWPRF News Article - Dramatically Improved Delivery Systems Promise More Effective Can | whytestocks | investorshangout | 06/11/2019 1:25:41 PM |
Looking good here $20 coming | weedtrader420 | investorshub | 06/11/2019 10:42:25 AM |
News, Short Squeeze, Breakout and More Instantly...
GWPH stock is moving up double-digits after GW Pharmaceuticals (NASDAQ:GWPH) reported a big jump in its cannabis-derived epilepsy drug, Epidiolex. The medicine uses CBD, and it is known to be an effective treatment for some types of epilepsy. Impressive Quarterly Numbers As everyone k...
CannabisNewsWire Editorial Coverage : As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state’s thriving industry. Sugarmade Inc. (OTCQB: SGMD) ( SGMD Profile ) is supporting many of these c...
The first passively managed, pure-play exchange-traded fund (ETF) for cannabis investing is now publicly available to investors. On Tuesday (July 9), Innovation Shares’ The Cannabis ETF (ARCA: THCX ) l aunched on NYSE Arca . The THCX focuses on companies in the legal cann...